baber/WOPTO huggingface dataset:
Patent NZ-524382-A (NZ)
Title: Adjustable hanger for hanging object on vertical surface
Inventor: BRUNTON WAYNE DAVID
IPC: A47G1/24
Filed: 2003-02-25
Abstract: Component 12 is typically fixed to a picture frame (not shown) and is pivotally connected to component 11 which is typically fixed to a wall. Component 12 has a serrated surface 15 which engages a finger 25 on component 11 to allow for pivotal adjustment of component 12 relative to component 11.
Patent NZ-527586-A (NZ)
Title: Non-dairy containing cereal dispersions made using enzyme preparations that hydrolyse cereal starch into a low viscosity oat-based milk or cream
Inventor: TRIANTAFYLLOU ANGELIKI OSTE
IPC: A23L7/104
Filed: 2002-02-13
Abstract: Efficient, selective, and economical methods for producing non-dairy, ready-to-use milk substitute cereal dispersions having intact beta -glucans, proteins, and natural sugars, while retaining the aroma and flavour of natural cereal. The methods include treating a cereal substrate suspension with an enzyme preparation that comprises at least one hydrolase having the ability to hydrolyse alpha -glycosidic bonds and having no glucanase and proteinase effect. The hydrolase may be selected from the group consisting of beta -amylase, alpha -amylase, amyloglucosidase and pullulanase, with the proviso that when the enzyme preparation comprises alpha -amylase or beta -amylase, there is always a mixture of at least one other of the alpha -glycosidic hydrolases. When beta -amylase and alpha -amylase are selected, they are used as a mixture, i.e., introduced simultaneously, to provide for accelerated enzymatic hydrolysis and for reduced amounts of the enzymes than otherwise needed if the enzymes were used separately . In addition to the hydrolases identified herein, the enzyme preparations of the present invention may further comprise an isomerase, such as glucose isomerase.
Patent NZ-529471-A (NZ)
Title: Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
Inventor: DI FABIO ROMANO
IPC: A61P5/02
Filed: 2002-05-21
Abstract: The compound of formula (I) is described wherein: A is a bind; X is nitrogen or CR3 Y is -C(R8)=; R1 is phenyl wherein at least one hydrogen atom is replaced with a substituent selected from the group consisting of halogen, cyano, a straight or branched saturated aliphatic hydrocarbon containing from 1 to 10 carbon atoms, a straight or branched saturated aliphatic hydrocarbon containing 1 to 10 carbon atoms attached through an oxygen bridge, a straight or branched saturated aliphatic hydrocarbon containing from 1 to 10 carbon atoms having at least one hydrogen atom replaced with halogen R2 is a straight or branched saturated aliphatic hydrocarbon containing 1 to 10 carbon atoms; R3 is hydrogen R4 is a straight or branched saturated aliphatic hydrocarbon containing from 1 to 10 carbon atoms or a straight or branched saturated aliphatic hydrocarbon containing 1 to 10 carbon atoms substituted by a straight or branched saturated aliphatic hydrocarbon containing from 1 to 10 carbon atoms attached through an oxygen bridge; R5 is hydrogen; R6 is hydrogen; and R8 is hydrogen. The compound can be used in pharmaceutical compositions for the treatment of conditions mediated by CRF(corticotrophin-releasing factor), such as depression, anxiety, IBS (irritable bowel disease and IBD (inflammatory bowel disease).
Patent NZ-532713-A (NZ)
Title: Bicyclic oxopyridine and oxopyrimidine derivatives
Inventor: DAVIS JEREMY MARTIN
IPC: A61P7/02
Filed: 2002-10-16
Abstract: Disclosed are compounds of formula (Ia), wherein: A is -C(Rb)= or -C(Rb)(Rc)-, Ra, Rb and Rc are independently H or optionally substituted alkyl, X is O or S, Y is N, CH or substituted C, n is 0 or 1, Alk1 is an optionally substituted aliphatic or heteroaliphatic chain, L1 is a bond, or linker atom or group, Cy1 is H, or optionally substituted cycloaliphatic, polycycloaliphati, heterocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic, Ar is an optionally substituted aromatic or heteroaromatic. The compounds are used in the manufacture of medicaments for the treatment of immune and inflammatory diseases.
Patent NZ-532793-A (NZ)
Title: Antitumoral analogs of ecteinascidin 743 (ET-743) having five membered fused ring ecteinascidin structure
Inventor: MANZANARES IGNACIO
IPC: C07D471/18
Filed: 2001-05-15
Abstract: Antitumour compounds have the five membered fused ring ecteinascidin structure of the formula (I) are disclosed, wherein these compounds lack a 1,4-bridging group as found in the ecteinascidins; they have a cyano group at the C-21 position; the other variables are as defined in the specification. (62) Divided out of 521807
Patent NZ-533232-A (NZ)
Title: Portable device and method for accessing data key actuated devices
Inventor: HOLLINGSHEAD DENNIS W
IPC: G07C9/00
Filed: 2001-12-06
Abstract: A method for accessing data key actuated devices (12) comprises: receiving a key actuated device identifier from a key actuated device (12); receiving a biometric (26); determining whether the received biometric is an authorized biometric; comparing the received key actuated device identifier with stored key actuated device identifiers and, on finding a matching stored key actuated device identifier and where the received biometric is an authorized biometric, retrieving a stored access key associated with the matching stored key actuated device (12) identifier; and transmitting the retrieved access key.
Patent NZ-539522-A (NZ)
Title: Solid pharmaceutical formulations comprising telmisartan
Inventor: NAKATANI MANABU
IPC: A61K9/20
Filed: 2003-09-18
Abstract: A pharmaceutical composition comprising 3 to 50 wt. % of telmisartan dispersed in a dissolving matrix comprising: a) a basic agent in a molar ration of basic agent : telmisartan = 1:1 to 10:1, b) a surfactant or emulsifier in an amount of about 1 to 20 wt.% of the final composition, c) 25 to 70 wt.% of a water-soluble diluent, d) optionally 0 to 20 wt.% of further excipients and/or adjuvants, the sum of all components adding to 100%.
Patent NZ-540848-A (NZ)
Title: Method and plant for desalinating salt-containing water
Inventor: VAN ELS HANS JOSEF
IPC: F24S90/00
Filed: 2003-11-26
Abstract: Method and plant for desalinating salt-containing water, wherein the salt-containing water is passed through a heat exchanger (5) disposed in a basin (1) containing brine, whereupon the salt-containing water that has been heated in the heat exchanger (5) is passed through an evaporator (9) for evaporating at least part of the salt-containing water, after which the vapor thus formed is introduced into a condenser (12) so as to obtain water from which the salt has been removed. The plant for desalinating salt-containing water comprises a basin (1) that contains brine, in which a heat exchanger (5) is disposed, wherein means (6) for supplying the water to be desalinated are connected to an inlet of the heat exchanger (5), whilst an outlet of the evaporator (9) is connected to means for condensing the water vapour that has been formed in the evaporator (13, 12).
Patent NZ-542792-A (NZ)
Title: Arch support insoles
Inventor: BAYLY MARK SIMON
IPC: A43B13/40
Filed: 2004-04-01
Abstract: A shoe insole for location within a shoe. The insole includes a pad (1) having a recess (7) formed between an upper surface (2) and a lower surface (8) of the pad adjacent an inner side (10). The recess is designed to receive an insert (14) for supporting an arch portion of a user's foot. The pad also includes a gap (11) extending longitudinally of the pad between the inner side (10) and outer side (12) to facilitate variation of a width dimension of the pad.
Patent NZ-548241-A (NZ)
Title: Method and apparatus for filling a radially flexible container
Inventor: OURS DAVID C
IPC: B65B9/18
Filed: 2004-12-02
Abstract: A diameter reducing system for reducing the diameter of a flexible container (12) as the container is filled. The system includes a stretching device (24) to stretch the container at the fill level as the container is filled with a plurality of particles. The stretching device can release a stretched portion (22) of the container substantially at the fill level as the fill level rises. The container can be a flexible, elastic bag. Shrinking of the container at the fill level as the container fills promotes supporting engagement between particles to enhance the structural integrity of the filled container and to reduce the likelihood that particles will be damaged during movement of the filled container.
Patent NZ-550893-A (NZ)
Title: Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation
Inventor: ASPBERG ANDERS
IPC: A61K31/737
Filed: 2005-04-26
Abstract: Disclosed is the use of chondroitin sulphate E (CS-E) or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of diseases or conditions related to collagen fibril formation, such as pulmonary fibrosis, wound healing, ulcers (e.g. peptic ulcer), chronic intestinal disease (e.g. ulcerative colitis, Crohn's disease or inflammatory bowel disease), rheumatoid arthritis, reconstructive skeletal formation, skeletal repair, facilitating healing after surgical treatment or transplantation, stimulating repair in damaged ligaments or tendons, or facilitating bone repair after severe fractures.
Patent NZ-552867-A (NZ)
Title: Method for protecting useful plants or plant propagation material
Inventor: WALTER HARALD
IPC: A01N43/56
Filed: 2005-08-11
Abstract: A method of controlling phytopathogenic diseases on useful plants or plant propagation material thereof, which comprises applying to said plant propagation material a fungicidally effective amount of a compound of formula (I) which is a specific subgroup of an ortho-cyclopropyl-carboxanilide derivative, wherein R1 is difluoromethyl and R2 is hydrogen.
Patent NZ-563686-A (NZ)
Title: Methods of treating cancer and other conditions or disease states using LFMAU and LDT
Inventor: CHENG YUNG-CHI
IPC: C07H19/048
Filed: 2006-06-05
Abstract: A pharmaceutical composition of general formula I in combination with one or more other anticancer agents.
Patent NZ-566291-A (NZ)
Title: Methods and devices for post processing rendered web pages and handling requests of post processed web pages
Inventor: WATSON DEREK JOHN
Filed: 2008-02-27
Abstract: A method of post processing a rendered HTML web page is disclosed. The method includes the steps of: receiving a rendered web page; parsing the web page to identify resources that the web page includes links to, combining a group of identified resources according to a type of resource, creating a resource reference that refers to each group of combined resources, and inserting the resource reference into the web page to enable the identified resources in the web page to be retrieved.
Patent NZ-566755-A (NZ)
Title: Safety needle with lockout mechanism via blocking member(s) that engage with end of hollow member proximal to user
Inventor: JONES SCOTT
IPC: A61M5/158
Filed: 2006-09-22
Abstract: A safety needle is provided which includes blocking structure to maintain a sharp tip of a needle safely within a housing and prevent re-advancement of a needle from a safety needle housing. The safety needle includes flexible blocking members positioned on an inner needle assembly which are configured to engage an outer housing after the needle assembly has been fully retracted within the outer housing. The engagement is at a proximal end of the housing (opposite the needle extension end).
Patent NZ-566762-A (NZ)
Title: Led module for torch with conductive housing and circuit board having a thermister to detect heat
Inventor: WEST STACEY H
IPC: H05B44/00
Filed: 2006-09-13
Abstract: Disclosed is an LED lighting module (40). The module includes a conductive housing including a first end (88), a second end (92), and a cavity (94); a light emitting diode (22) disposed on the first end of the conductive housing; and a circuit board (32) including a module circuit electrically coupled to the light emitting diode. The circuit board is at least partially contained within the cavity of the housing, with the module circuit including a thermistor to sense heat from the light emitting diode.
Patent NZ-567940-A (NZ)
Title: Aqueous herbicidal compositions comprising glyphosate potassium, lauryldimethylamine oxide and a polar water miscible solvent
Inventor: GIOIA PAUL
IPC: C09K23/18
Filed: 2006-11-09
Abstract: Disclosed are aqueous herbicidal compositions which comprise at least 360 g/L of an aminophosphate or aminophosphinate potassium salt (such as glyphosate potassium); at least 80 g/L of an alkyl dimethyl amine oxide surfactant such as lauryldimethylamine oxide, and as represented by the general formula R(CH3)2N+-O-; wherein R is a linear or branched alkyl group having an average number of carbon atoms of from 8 to 30; and a water-miscible solvent selected from N-methyl-pyrrolidone (NMP), a diester solvent, propylene carbonate, acetophenone, ethylene glycol butyl ether, diethylene glycol butyl ether, methoxy methyl butanol, propylene glycol methyl ether, dipropylene glycol methyl ether, g-butyrolactone, dimethyl formamide (DMF), furfuryl alcohol, tetrahydrofuryl alcohol, neopentyl glycol, hexadiols, hexylene glycol, glycol ether amines, ethylene glycol monoacetate, or mixtures thereof.
Patent NZ-568602-A (NZ)
Title: Liquid formulations of carboxamide arthropodicides
Inventor: GUTSCHE OLIVER WALTER
IPC: A01N63/40
Filed: 2006-12-27
Abstract: Disclosed is an arthropodicidal suspension concentrate composition comprising by weight based on the total weight of the composition of (a) about 0.1 to about 40 percent of at least one carboxamide arthropodicide e.g. 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, (b) 0 to about 20 percent of at least one other biologically active agent, (c) about 30 to about 95 percent of at least one water-immiscible liquid carrier, (d) about 0 to about 50 percent of at least one emulsifier, (e) about 0.01 to about 10 percent of a silica thickener, (f) about 0.1 to about 10 percent of at least one protic solvent selected from water, an alkanol and glycol and (g) about 0.001 to about 5 percent of at least one water-soluble carboxylic acid. Also disclosed is a method of controlling an arthropod pest comprising administering said suspension.
Patent NZ-571894-A (NZ)
Title: Brassica oleracea plants with a resistance to mycosphaerella brassicicola wherein the resistance gene originates from a B. oleracea plant the seeds of which have been deposited under PTA-7413
Inventor: BARTEN PIET
IPC: A01H5/10
Filed: 2007-04-12
Abstract: Disclosed is a Brassica oleracea plant, comprising a resistance gene to Mycosphaerella brassicicola, wherein said resistance gene provides a monogenic and dominant resistance to M. brassicicola, and wherein the resistance gene originates from a B. oleracea plant, the seeds of which have been deposited at the American Type Culture Collection (ATCC Patent Depository, 10801 University Boulevard, Manassas, VA 20110, United States of America) on 1 March 2006 under number PTA-7413.
Patent NZ-574618-A (NZ)
Title: Metered dosage dispenser closure for powders
Inventor: ALBAUM GARY J
IPC: A47G19/32
Filed: 2009-02-03
Abstract: A metric type dosage distributor closure for the powder is provided, which efficiently can distribute the powdered drink and can measure it. A metric type dosage distributor closure for the powder comprises: an opening of container; an annular ring (30) including the central part having one or more openings; and a cross member spanning the central part of the annular ring. The annular ring is adhered to the valve which is measured in order to shut opening tightly. The valve has the upper side and side and is biased in the sealing position.
Patent NZ-577342-A (NZ)
Title: Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Inventor: HENTEMANN MARTIN
IPC: A61K31/517
Filed: 2007-12-05
Abstract: Disclosed is a compound of formula (I) or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof, wherein: R1 is -(CH2)n-(CHR4)-(CH2)m-N(R5)(R5'); R2 is a heteroaryl optionally substituted with 1, 2 or 3 R6 groups; R3 is alkyl or cycloalkyl; and R4-R7 are as defined within the claims.
Patent NZ-580288-A (NZ)
Title: A MEMS microphone including a case, a MEMS membrane, and a mesh covering
Inventor: ALTMAN NATHAN
IPC: H04R19/00
Filed: 2008-03-14
Abstract: A MEMS microphone is disclosed. The MEMS microphone comprises a case, a MEMS membrane, and a mesh covering. The case has a front side, open to the exterior with an interior volume having a longest dimension being less than half of a wavelength of a highest operating frequency, and a closed side. The MEMS membrane is mounted on one face of a base where the base is mounted inside the case on the closed side. The mesh covers the front side. The open front side covered by the mesh is substantially transparent acoustically to at least some of a range of operating frequencies at which the microphone is sensitive where the range comprises ultrasound frequencies and defines the highest operating wavelength.
Patent NZ-582558-A (NZ)
Title: Nano-PCR: Methods and devices for nucleic acid amplification and detection
Inventor: GOEL ANITA
IPC: C12P19/34
Filed: 2005-05-13
Abstract: Disclosed is a device for applying tension to a nucleic acid sequence. The device includes one or more fluid channels, a means of retaining nucleic acid molecules within the one or more fluid channels and a means for applying a variable and controlled amount of tension to the nucleic acid molecules retained therein. The device further includes one or more chambers for reacting, storing, or introducing reagents. The reagents may include nucleic acid primers, nucleotide triphosphates, and polymerase.
Patent NZ-583167-A (NZ)
Title: Equipment and method for manufacturing steel-plastic composite pipe using reuseable steam
Inventor: ZHANG MINGWEI
IPC: B21C37/06
Filed: 2008-08-07
Abstract: Method and equipment for manufacturing steel-plastic composite pipe involve the steel-plastic composite pipe is heated using steam as heating medium. Said equipment involves multifunctional composite workroom, multifunctional pipe transfer car (39), steam circulating device and refrigerant forming device (11,12,17,22,23,42), also involves control device and circulating device which can provide reusable steam continuously. The steam circulating device comprises double heating furnace and adding steam device. This method has lower production cost and fewer labor intensity.
Patent NZ-592980-A (NZ)
Title: Enantiomerically enriched aryloazol-2-yl cyanoethylamino paraciticidal compounds
Inventor: SOLL MARK DAVID
IPC: C07D249/18
Filed: 2009-11-13
Abstract: 592980 Disclosed herein are aryloazol-2-yl-cyanoethylamino derivatives of formula (I), wherein the variables are defined in the specification, processes for their preparation, and a method for treating parasitic infection or infestation in a non-human animal comprising administering said derivatives. Specifically wherein the parasite is Anaplocephala, Ancylostoma, Anecator, Ascaris, Brugia, Bunostomum, Capillaria, Chabertia, Cooperia, Cyathostomum, Cylicocyclus, Cylicodontophorus, Cylicostephanus, Craterostomum, Dictyocaulus, Dipetalonema, Dipylidium, Dirofilaria, Dracunculus, Echinococcus, Enterobius, Fasciola, Filaroides, Habronema, Haemonchus, Metastrongylus, Moniezia, Necator, Nematodirus, Nippostrongylus, Oesophagostumum, Onchocerca, Ostertagia, Oxyuris, Paracaris, Schistosoma, Strongylus, Taenia, Toxocara, Strongyloides, Toxascaris, Trichinella, Trichuris, Trichostrongylus, Triodontophorous, Uncinaria or Wuchereria. Specific embodiments of the compound include: (+)-N-[2-(6-bromo-2H-pyrazolo[4,3-b]pyridin-2-yl)-1-cyano-1-methylethyl]-4- trifluoromethoxybenzamide, N-[1-cyano-2-(6,7-dichloro-2H-indazol-2-yl)-1-methylethyl] trifluoromethoxybenzamide, methyl 6-chloro-2-[2-cyano-2-({ [4-(trifluoromethoxy)phenyl]carbonyl} -amino)propyl]-2H-benzotriazole-4-carboxylate, and N-[2-(5-chloro-4,7-dimethyl-2H-benzotriazol-2-yl)-1-cyano-1-methylethyl]-4-trifluoromethylthiobenzamide.
Patent NZ-599106-A (NZ)
Title: Novel arylated camphenes, processes for their preparation and uses thereof
Inventor: MECHOULAM RAPHAEL
IPC: A61K31/09
Filed: 2010-11-18
Abstract: 599106 Described herein are arylated camphenes of formula (I), processes for their preparation and uses thereof for the manufacture of medicaments for the treatment of diseases, disorders or conditions associated with, or benefiting from stimulation of CB2 receptors. Specific embodiments of the arylate camphenes include the following: methyl-2-(2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl)-7,7-dimethylbicyclo[2.2.1]hept-2-ene-1-carboxylate; 2-(2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl)-1,7,7-trimethylbicyclo[2.2.1]hept-2-ene; and 2-(4-(hydroxymethyl)-7,7-dimethylbicyclo[2.2.1]heptan-2-yl)-5-(2-methyloctan-2-yl)benzene-1,3-diol.
Patent NZ-602688-A (NZ)
Title: Spray-pumpable composition suitable for topical skin application
Inventor: VAN DE LOCKAND PETRUS RICHARDUS MARINUS
IPC: C01B33/157
Filed: 2011-03-17
Abstract: Disclosed is a spray-pumpable topical composition comprising 0.01-0.5 weight percent unbound hydrophilic silicon dioxide particles (e.g. colloidal silica such as Cab-o-sil, Aerosil 200 etc.); an emulsifier; at least one active ingredient selected from zinc oxide titanium dioxide, a steroid hormone, an antimicrobial agent, an antibacterial agent, an antifungal agent, an antibiotic or any combination thereof; and one or more additives, and wherein the composition is an emulsion. Also disclosed is a method for the preparation of a spray-pumpable topical composition, comprising the steps of a) preparing a lipophilic phase comprising at least one active ingredient selected from zinc oxide, titanium dioxide, a steroid hormone, an anti-microbial agent, an antibacterial agent, an antifungal agent, an antibiotic or any combination thereof and optional additives; b) preparing an aqueous phase comprising 0.01-0.5 weight percent hydrophilic silicon dioxide (Aerosil 200) and optional additives, wherein the hydrophilic silicon dioxide is present as unbound hydrophilic silicon dioxide particles, and the lipophilic and/or hydrophilic phase comprises an emulsifier; and, c) mixing the lipophilic phase of step a) with the aqueous phase of step b) to obtain the spray-pumpable topical composition. Further disclosed is the use of 0.01–0.5 weight percent unbound hydrophilic silicon dioxide particles (Aerosil 200) in the preparation of a spray-pumpable topical suspension in an emulsion comprising 0.01-0.5 weight percent unbound hydrophilic silicon dioxide particles.
Patent NZ-603725-A (NZ)
Title: 6-cycloalkyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
Inventor: EICKMEIER CHRISTIAN
IPC: C07D487/04
Filed: 2011-08-09
Abstract: The disclosure relates to a class of 6-cycloalkyl-pyrazolopyrimidinone (a ketone of a pyrazolopyrimidine structure) compounds according to the drawing, wherein R1 and D are defined in the specification. The compounds of the invention show PDE9 inhibiting properties. These compounds can then be used as the active entity of medicaments, or for the manufacture of medicaments, for the treatment of conditions concerning deficits in perception, concentration, learning or memory, including Alzheimers disease and schizophrenia.